Pomaglumetad Effects on Glutamate Biomarkers

NCT02919774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Healthy Controls

Interventions

DRUG: POMA
DRUG: placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]